PASG — PASSAGE BIO INC

Ownership history in Squarepoint Ops LLC  ·  16 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in PASSAGE BIO INC (PASG). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2021 Q1)
Avg. % of fund
0.0%
First filed
2020 Q3
Last filed
2025 Q4
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 10,799 -12,701 -54.0% 0.00% $127K $11.80
2025 Q3 REDUCED 23,500 -40,641 -63.4% 0.00% $188K $8.03
2025 Q1 ADDED 64,141 +42 +0.1% 0.00% $23K $7.06
2024 Q4 ADDED 64,099 +36,172 +129.5% 0.00% $36K $11.34
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PASG price (monthly, adj. close)

Other funds also holding PASG

As of 2025 Q4 — sorted by position size

Lynx1 Capital Management LP 3Y 1.49% Vestal Point Capital, LP 0.12% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.1% Yiheng Capital Management, L.P. 3Y 7Y 0.08% Eversept Partners, LP 3Y 7Y 0.08% Erste Asset Management GmbH 0.01% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% Quadrature Capital Ltd 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0%
← Back to Squarepoint Ops LLC Holdings